North America Orthopedic Biomaterials Market Size & Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic biomaterials market will help companies and investors design strategic landscapes.

Ceramics & bioactive glass biomaterials was the largest segment with a revenue share of 32.57% in 2023. Horizon Databook has segmented the North America orthopedic biomaterials market based on ceramics & bioactive glass biomaterials, polymers biomaterials, calcium phosphate cements, metal biomaterials, composites covering the revenue growth of each sub-segment from 2018 to 2030.

Key factors driving the market growth in the region are presence of key manufacturers and growing prevalence of osteoporosis, arthritis, and sport-related injuries. The region has a large geriatric population, which is at a risk of developing musculoskeletal disorders, owing to weak joints and low bone mass. To restore movement, they either opt for orthopedic implants or temporary relief options such as visco supplementation.

Also, the rise in the number of sport-related injuries and bone fractures in the recent years has also created a strong demand for orthopedic biomaterials in the region. Moreover, purchasing power of the consumers in this region is very high, owing to which the demand for premium quality biomaterials is high. In addition, ongoing research on biodegradable materials and rise in number of research institutes funded by government is further anticipated to drive the market.

Furthermore, many key market participants are operating in this region with their manufacturing, distribution, and R&D units. The U.S. is currently the main market for orthopedic biomaterials. The regulatory norms and approval processes in Canada are similar to those in the U.S. Owing to this, many U.S.-based players have started operations or expanded their distribution network in Canada. Thus, making North America a leader in the global orthopedic biomaterials market.